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Abstract
Background: Killer cell immunoglobulin-like receptors (KIRs) are a family of inhibitory and activatory receptors that
are expressed by most natural killer (NK) cells. The KIR gene family is polymorphic: genomic diversity is achieved through
differences in gene content and allelic polymorphism. The number of KIR loci has been reported to vary among
individuals, resulting in different KIR haplotypes. In this study we report the genotypic structure of KIRs in 217 unrelated
healthy Italian individuals from 22 immunogenetics laboratories, located in the northern, central and southern regions of
Italy.
Methods: Two hundred and seventeen DNA samples were studied by a low resolution PCR-SSP kit designed to identify
all KIR genes.
Results: All 17 KIR genes were observed in the population with different frequencies than other Caucasian and non-
Caucasian populations; framework genes KIR3DL3, KIR3DP1, KIR2DL4 and KIR3DL2 were present in all individuals. Sixty-
five different profiles were found in this Italian population study. Haplotype A remains the most prevalent and genotype
1, with a frequency of 28.5%, is the most commonly observed in the Italian population.
Conclusion: The Italian Caucasian population shows polymorphism of the KIR gene family like other Caucasian and non-
Caucasian populations. Although 64 genotypes have been observed, genotype 1 remains the most frequent as already
observed in other populations. Such knowledge of the KIR gene distribution in populations is very useful in the study of
associations with diseases and in selection of donors for haploidentical bone marrow transplantation.
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Background
Killer cell immunoglobulin-like receptors (KIRs) are glyc-
oproteins expressed on the cell surface of natural killer
(NK) and subsets of T cells. These polymorphic receptors
interact with specific motifs on HLA class I molecules,
modulate NK cytolytic activity and are encoded by genes
located on chromosome 19q13.4 [1-3].
They have been divided into distinct groups, depending
on the number of external immunoglobulin domains (2D
or 3D). The presence of a long cytoplasmatic tail with two
immune tyrosine-based inhibitory motifs (ITIMs) allows
the transduction of inhibitory signals and characterizes
the inhibitory KIRs (2DL, 3DL), whereas the presence of
short cytoplasmatic tails corresponds to the activating KIR
receptors (2DS, 3DS) [1-4].
Due to the functional link between HLA class I molecules,
KIRs are expected to display a high polymorphism. Stud-
ies on KIR genes in different populations, along with HLA
system evaluations, can provide valuable information
about the history and geography of human genes, while a
wide range of genotypes may be expected in the human
populations [5-8].
Most KIR haplotypes belong to one of two broad groups,
termed A and B. The haplotypes have a framework of three
conserved blocks containing KIR3DL3,  KIR2DL4  and
KIR3DL2 and differ in the number and type of KIR genes.
Group A haplotype has a unique combination of seven
KIR genes, while B haplotype exhibits a substantial varia-
bility in KIR gene number. Both groups of genotypes have
been found in all populations analysed so far, but their
distribution varies considerably among ethnic groups
[5,9,10].
Several studies have associated KIR genes with disease sus-
ceptibility, immune responsiveness and events following
allogenic transplantation; recent reports have implicated
KIRs in affecting the outcome of hematopoietic stem-cell
transplantation [11].
The aim of this multicentric study was to determine the
percentage of the population positive for individual KIR
genes and the genotype pattern in a representative ethnic
Italian group of 217 samples, using a new low-resolution,
gene-level KIR PCR-SSP typing; we compare the data so
obtained with those previously described in other Cauca-
sian and non-Caucasian populations
Materials and methods
217 unrelated healthy Italian individuals from 22 immu-
nogenetics laboratories located in northern, central and
southern regions of Italy were randomly selected to repre-
sent a fair, representative ethnic Italian group.
Each laboratory typed 10 DNA samples. DNA was previ-
ously extracted from peripheral blood samples drawn in
EDTA anticoagulant tubes by standard protocols (e.g. salt-
ing-out); the DNA concentration and the ratio were eval-
uated. All participating laboratories performed KIR typing
using the same low resolution PCR-SSP assay and the
same lot number (KIR Genotyping Kit, Dynal Biotech,
Pel-Freez Clinical Systems, Brown Deer, WI, USA) follow-
ing the manufacturer's instructions. The kit was designed
to identify 14 KIR genes (2DL1, 2DL2, 3DL1, 2DL4, 2DL5,
2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3,
3DS1), 2 pseudogenes (2DP1 and 3DP1) and the com-
mon variants of KIR2DL5  (KIR2DL5A, KIR2DL5B), the
KIR2DS4 allele (*001/002 and *003) and KIR3DP1 allele
(*001/002 and *003).
The specificity of the assay was previously tested by all
participating laboratories on a panel of two shared DNA
chosen by two reference laboratories to cover the amplifi-
cation of all mixes included in the typing kit.
PCR-SSP was performed following the manufacturer's
instructions. Briefly, 25 µl of DNA at a concentration of
75–125 ng/µl with ratio > 1.5 was mixed with 150 µl of
PCR Buffer, 2.4 µl of Taq polymerase and 85 µl of distilled
water. Eight µl of this mixture was added to each mix
except for the contamination control where a mixture
without DNA was used.
Genomic polymerase chain reaction analysis was per-
formed under the conditions recommended by the man-
ufacturers: 1 minute at 95°C for one cycle followed by 30
cycles formed of 20 seconds at 94°C, 20 seconds at 63°C
and 90 seconds at 72°C. At the end a constant tempera-
ture of 4°C was maintained.
PCR products was transferred to the well of a 2% agarose
gel capable of resolving 50–2000 base pair fragments of
DNA. The DNA separation was performed at 150 volts for
22–25 minutes. The amplification was checked on a UV
transilluminator and photographed. The typing was inter-
preted by a worksheet.
Statistical analysis was performed as follows: the percent-
age of the population positive for KIR genes was deter-
mined by direct counting. Differences between
populations were compared by χ2 and Yates-corrected P-
values for the number of loci investigated.
Linkage disequilibrium (∆) for two loci associations was
calculated according to Mattiuz et al. [12]. The relative
linkage disequilibrium (∆r), which gives an indication of
the strength of associations between pairs of sequences,
was calculated for each pair using ∆max and the observed
two-locus haplotype frequency [13]. The differencesJ
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Table 1: Comparison of the KIR gene frequency observed in the Italian multicentric study with Caucasian and non-Caucasian populations.
KIR gene Italian Study 
(n.217) (%)
Australian 
Caucasian 
Witt et al. 
(n.145) (%)
Irish Crum et 
al. (n.90) (%)
Germany 
Uhrber et al. 
(n.120) (%)
German Becher 
et al. (n.90) (%)
Greek Niokou 
et al. (n.233) (%)
North Indian 
Rajalingam et al. 
(n.72) (%)
Vietnamese 
Toneva et al. 
(n.59) (%)
Australian 
Aborigine 
Toneva et al. 
(n.67) (%)
Thailandia 
Norman et al. 
(n.119) (%)
Palestinian 
Norman et al. 
(n.105) (%)
Afro 
Caribbean 
Cook et al. 
(n.54) (%)
Asian Cook et 
al. (n.35) (%)
Chinese Han 
Jiang et al. 
(n.104) (%)
Japanese 
Yawata et al. 
(n.41) (%)
2DL1 95 96 §84 P0.009 93 87 89 91 98 §72 P0.0001 97 §83 P0.004 90 86 99 100
2DL2 53 §31 
P0.0001
50 56 50 50 79 P0.0001 37 78 P0.003 42 62 54 54 17 P0.0001 §17 P0.0001
2DL3 88 95 90 87 §65 P0.0001 88 91 98 §65 P0.0001 97 85 91 86 99 P0.0001 100
2DL5A 33 nt nt #44 #79 nt nt nt nt nt nt #33 #26 31 #39
2DL5B 28 nt Nt nt nt nt nt nt nt nt nt nt nt 6 P0.0001 nt
2DS1 36 51 56 37 39 43 54 38 82 P0.0001 42 44 17 49 34 34
2DS2 53 51 51 62 49 54 62 41 84 P0.0001 44 64 52 57 17 P0.0001 §17 P0.0001
2DS3 33 28 27 28 22 37 43 31 81 P0.0001 25 37 24 29 12 P0.0001 §17 P0.0001
2DS4 
*001-
*002
33 #nt #nt #nt #nt #nt #nt #nt #nt #nt #nt #nt #nt 80 P0.0001 #nt
2DS4* 
003
89 92 96 98 96 88 80 87 81 87 88 78 83 42 P0.0001 96 P0.0001
2DS5 28 nt 35 26 27 21 47 P0.002 nt nt 23 27 30 51 P0.008 23 28
3DL1 96 96 92 96 §87 P0.0003 90 91 89 §57 P0.0001 93 88 98 91 94 97
3DS1 35 nt Nt nt 36 46 39 41 78 P0.0001 44 39 17 40 32 33
§ With the exception of the Chinese Han population, the primers used were not the same as in the Italian study and hence cannot afford a real comparison. However, any higher percentages of detection are 
significant. # It should be noted that values given for 2DL5 and 2DS4*003 may contain 2DL5B and 2DS4*001/002 positivities where the latter alleles are reported as not-tested (nt).Journal of Translational Medicine 2006, 4:44 http://www.translational-medicine.com/content/4/1/44
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Table 2: Linkage disequilibrium values of KIR associations.
2DL2 2DL3 2DL5A 2DL5B 2DS1 2DS2 2DS3 2DS4* 
001-002
2DS4* 
003
2DS5 3DL1 3DS1
2 ∆ -0.004 0.097 0.025 0.019 0.01 0.004 0.036 0.03 0.001 0.006 0.031 0.003
D R -0.055 0.69 0.597 0.586 0.241 0.055 0.924 0.761 0.011 0.193 0.201 0.064
L H 0.246 0.623 0.168 0.14 0.15 0.246 0.18 0.117 0.539 0.115 0.685 0.159
1 P < 0.0001 < 0.05
2 ∆ -0.137 0.014 0.101 0.013 0.205 0.099 0.012 -0.031 0.003 -0.005 0.025
D R -1.186 0.106 0.990 0.096 0.944 0.811 0.1 0.295 0.026 0.087 0.196
L H 0.071 0.07 0.149 0.077 0.304 0.156 0.071 0.181 0.05 0.252 0.087
2 P < 0.0001 < 0.0001 < 0.0001 < 0.0001
2 ∆ 0.001 -0.096 0.001 -0.115 -0.086 -0.022 0.025 -0.016 0.007 -0.028
D R 0.022 -1.774 0.012 -1 -1.333 -0.347 0.120 -0.301 0.054 -0.407
L H 0.12 0.005 0.135 0.092 0.032 0.1 0.471 0.084 0.549 0.102
3 P < 0.0001 < 0.001 < 0.001
2 ∆ 0.02 0.135 0.022 0.04 -0.05 -0.052 0.108 -0.051 0.133
D R 0.162 0.886 0.167 0.269 -0.341 -0.835 0.887 -1.35 0.863
L H 0.047 0.171 0.078 0.071 -0.016 0.069 0.135 0.096 0.168
5A P < 0.0001 < 0.001 < 0.0001 < 0.05
2 ∆ 0.019 0.104 0.119 -0.01 -0.022 0.01 -0.035 0.018
D R 0.162 1.022 0.969 -0.078 -0.445 0.071 -1.157 0.147
L H 0.050. 0.152 0.146 0.02 0.08 0.032 0.1 0.048
5B P < 0.0001 < 0.0001
2 ∆ 0.021 0.028 -0.05 -0.08 0.115 -0.047 0.127
D R 0.156 0.195 -0.348 -1.212 0.962 -1.18 0.839
S H 0.085 0.064 0.012 0.056 0.146 0.119 0.167
1 P < 0.05 < 0.0001 < 0.05 < 0.0001 < 0.0001
2 ∆ 0.106 0.016 -0.02 0.01 -0.005 0.025
D R 0.868 0.132 0.185 0.103 -0.087 0.196
SH 0 . 1 6 3
2 P < 0.0001 0.075 0.192 0.058 0.252 0.087
2 ∆ -0.011 -0.032 0.003 -0.051 0.04
DR -0.076 -0.537 0.028 -1.425 0.275
SH 0.022 0.09 0.031 0.096 0.075
3P < 0.001
2 ∆ -0.107 -0.039 0.0003 -0.039
DR -1.811 -0.321 0.009 -0.271
SH 0.019 0.011 0.155 -0.003
4*001 
*002
P < 0.0001 < 0.01 < 0.05
2 ∆ -0.061 0.108 -0.07
DR -1.24 0.804 -1.108
SH 0.041 0.661 0.063
4*003 P < 0.05 < 0.000 < 0.05
2 ∆ -0.056 0.105
DR -1.876 0.862
SH 0.068 0.135
5P < 0.05 < 0.0001
3 ∆ -0.076Journal of Translational Medicine 2006, 4:44 http://www.translational-medicine.com/content/4/1/44
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between the observed and expected haplotype frequencies
were compared by Yates χ2 contingency tables.
Results
All participating laboratories had the same typing of the
two shared DNA. No ambiguities were observed and no
false or negative results were described by the laboratories.
The frequencies of the KIR genes are compared to other
Caucasian and non-Caucasian populations in table 1.
The KIR2DL4, KIR3DL2, KIR3DL3 framework genes were
found in all individuals whereas all other inhibitory and
non-inhibitory genes were present in a varying percentage
of individuals.
KIR2DL1 gene was present in 95% of the Italian Cauca-
sian population, while in the Australian Aborigine, Pales-
tinian and in Irish populations it is found at the lowest
frequency (72, 83 and 84 percent, respectively) [8,14,15].
The frequency of KIR2DL2 was 53% in the Italian popula-
tion which was higher than in the Australian Caucasian,
Chinese Han and Japanese but lower than the Australian
Aborigine (78%) and North Indian (79%) populations
[6,8,16-18]. KIR2DL3 and KIR3DL1 have a frequency sim-
ilar to that observed in the Caucasian population, except
for a German regional population described by Becker
and in the Aborigine population which were both lower
[8,19,20]; in Chinese Han and Japanese populations the
frequency was higher [17,18].
The non-inhibitory KIR2DS1, KIR2DS2, KIR2DS3 genes
have a frequency lower than observed in the Australian
Aborigine population (p < 0.005) but higher than in the
Chinese Han and Japanese population, though only for
KIR2DS2 and KIR2DS3 [8,17,18].
KIR2DS4 gene was present in a high percentage in the Ital-
ian population; the expression of allele *003 which iden-
tifies the gene variant was present in 89% of subjects
studied, as compared to alleles *001 and *002, which are
only represented in 33% of the population [21]. A reverse
positivity of the alleles was observed to that of the Chinese
Han population [17].
KIR2DS5 gene has a frequency similar to other Caucasian
populations, but is lower than that observed in Asian pop-
ulations, while KIR3DS1 has a frequency similar to other
Caucasian and non-Caucasian populations except in the
Aborigines in whom it is present in a double percentage
[7,8,16].
Linkage distribution (LD) and relative LD values show sig-
nificant differences between individual KIR pairs (Table
2).
Among the main inhibitory KIRs, we showed a positive
linkage disequilibrium between KIR2DL1 and KIR2DL3
whereas KIR2DL2 is in negative linkage with KIR2DL3.
About the only non-inhibitory gene observed in genotype
1, KIR2DS4*001/002 is negatively linked with its variant
KIR2DS4*003.
The main pairs of KIR genes that show a significant posi-
tive and negative linkage disequilibrium are summarized
in table 3.
The KIR repertoire is substantially influenced by the poly-
morphic and polygenic nature of the KIR gene. In all, 65
DR -2.01
LH 0.085
1P < 0.05
∆ = linkage disequilibrium parameters;R = relative linkage disequilibrium;H = estimated two locus haplotype frequency;P = p value
Table 2: Linkage disequilibrium values of KIR associations. (Continued)
Table 3: Pairs of KIR genes that show significant positive and negative linkage disequilibrium
Positive linkage disequilibrium Negative linkage disequilibrium
2DL1-2DL3, 2DL1-2DS3 2DL2-2DL3
2DL2-2DL5B, 2DL2-2DS2, 2DL2-2DS3 2DL3-2DL5A, 2DL3-2DS2, 2DL2-2DS30
2DL5A-2DS1, 2DL5A-2DS3 2DL5A-2DS4*001-02, 2DL5A-2DS4*003
2DL5B-2DS2, 2DL5B-2DS3 2DS1-2DS4*001-002, 2DS1-2DS4*003
2DS1-2DS3, 2DS1-2DS5, 2DS1-3DS1 2DS4*001-002-2DS4*003,
2DS2-2DS3 2DS4*001-002-2DS5, 2DS4*001-002-3DS1
2DS3-3DS1 2DS4*003-2DS5
2DS4*003-3DL1, 2DS4*003-3DS1 2DS5-3DL1
2DS5-3DS1 3DL1-3DS1Journal of Translational Medicine 2006, 4:44 http://www.translational-medicine.com/content/4/1/44
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different profiles were found in the Italian population
without pseudogenes and 74 if we include KIR2DP1 and
KIR3DP1 among the 217 samples tested.
Genotypes containing between 6 and 15 genes are
included. Genotypes with seven and eleven genes are the
most represented in the study population, respectively in
44 and 45 cases.
Following the Uhrberg classification, out of the 65 geno-
types identified the most frequent are genotypes 1, 2, 3, 4,
6, 7, 12, 5 and 9 with a frequency of 28.5%, 12.9%, 9.2%,
8.3%, 4.6%, 3.6%, 3.6%, 2.3% and 1.3% respectively
(Table 4) [4].
In particular, genotype 1, observed in 62 samples with a
frequency of 28.5%, closely resembles that observed in
the other Caucasian, Palestinian and Thai populations,
but not in the Indian and Aborigine populations, which
have a frequency of 5.6% and 1.7%, respectively
[5,6,8,15,16]. In this genotype the expression of KIR2DS4
is related to the homozygous allele *003 in 39 out of 62
and in 20 out of 62 samples in heterozygous combina-
tions with allele *001/*002.
Genotype 2 was present in 28 people with a frequency of
12.9%; it includes the inhibitory gene KIR2DL2 and has a
frequency higher than that observed in other Caucasian
and non-Caucasian populations or in the Palestinian and
Thai populations which have a similar frequency [6,8,15].
In this case KIR2DS4*003  is in heterozygous and
homozygous combinations in 11 and 16 out of 28 indi-
viduals, respectively.
Genotype 3 with a frequency of 9.2% (20 samples) always
includes gene KIR2DL2 and has a frequency that is higher
than the Australian Caucasian, Greek and German popu-
lations, while it has a similar percentage to that observed
in another German study and in a Palestinian population
study [5,6,19]. Genotypes included KIR2DL5  which is
only positive in the variant KIR2DL5B, while KIR2DS4 is
positive for the homozygous allele *003 in 16 samples.
Genotype 4, observed in 18 people with a frequency of
8.3%, is lower than that observed in Australian Caucasian
and Irish populations but similar to that observed in other
Caucasian and non-Caucasian studies [6,8,14]. In this
genotype  KIR2DL5  is always positive in the variant
KIR2DL5A  while  KIR2DS4  is positive in homozygous
combination for the allele *003 in 80% of this genotype.
Genotype 6 includes all inhibitory and non-inhibitory
genes and is present in 10 cases (4.6%) somewhat similar
to the position observed in the Caucasian and non-Cauca-
sian populations but not in the Australian Aborigine [6].
In this genotype the two variants of KIR2DL5 are equally
expressed while KIR2DS4*003 is present in 8 out of 10
cases.
Table 4: Distribution of the main phenotypes observed in the Italian population. The nomenclature system from Uhrberg is used for 
describing the patterns (5). Each genotype is also shown in the different patterns due to the distribution of KIR2DS4 alleles and the 
KIR2DL5 variants.
G e n o t y p e s N u m b e r F r e q u e n c y  % 222222222 2 2 23333
DDDDDDDDD D D DDDDD
LLLLLLSSS S S SLLLS
123455123 4 4 51231
A B *001–*002 *003
1 3 9 2 8 . 5 +-+ +----- - + - + + + -
1 2 0 +-+ +----- + + - + + + -
1 3 +-+ +----- + - - + + + -
2 1 1 ++++- - -+- - + -+++-
2 1 6 1 2 . 9 ++++- - -+- + + -+++-
2 1 ++++- - -+- + - -+++-
3 1 6 9 . 2 ++++-+-++ - + -+++-
3 4 ++++-+-++ + + -+++-
4 1 7 8 . 3 +-+++-+- - - + +++++
4 1 +-+++-+- - + - +++++
6 8 4 . 6 +++++++++ - + +++++
6 2 +++++++++ + - +++++
7 3 3 . 6 +++++-+++ - + -++++
7 4 +++++++++ - + -++++
7 1 +++++++++ + - -++++
1 2 8 3 . 6 +++++-++- - + +++++Journal of Translational Medicine 2006, 4:44 http://www.translational-medicine.com/content/4/1/44
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Genotype 7, which includes all inhibitory and non-inhib-
itory genes except KIR2DS5, has a frequency of 3.6%
which is lower than has been observed in other Caucasian
populations, similar to the finding in Palestinian and Thai
studies and much lower than in the Australian Aborigine
population [6-8,15].KIR2DL5A is positive in all samples
and  KIR2DL5B  in about half. Allele KIR 2DS4*003 is
observed in 7 out of 8 samples.
Genotype 12 has a percentage of 3.6%, similar to that
observed in other Caucasian and non-Caucasian popula-
tions except in Australian Caucasians where it is higher
[6]. In these 8 samples we only have positivity in genes
KIR2DL5A and KIR2DS4*003.
Genotypes 5 and 9, which are characterized by positivity
for KIR2DL1 and KIR2DL2 and negativity for KIR2DL3,
have a frequency of 2.3% and 1.3% respectively.
The A putative homozygote haplotypes in the Italian pop-
ulation are the most prevalent (57%) and the distribution
of genotypes in terms of combination of haplotypes
proves to be AA 28.5%, AB 69.5% and BB about 2% [10].
Pseudogene typing shows a close correlation between
KIR2DP1 and haplotype A while it is absent in haplotype
B. Haplotype A is also characterized by the presence in all
samples of allele KIR3DP1*003, while genotype B in our
four samples only shows positivity for KIR3DP1*001/002
[21].
Discussion
In this work we evaluated the percentage of the popula-
tion positive for each KIR gene as well as the KIR genotype
frequency in a representative ethnic Italian group of 217
randomly selected unrelated healthy individuals from 22
immunogenetics laboratories, located in northern, central
and southern regions of Italy.
All the participating laboratories studied the two shared
DNA samples and the results showed typing consensus.
Each KIR gene was detected by a single primer mix and no
ambiguities were observed. Management of the new kit
was acceptable by all laboratories.
The percentage of the population positive for a KIR gene
was compared to other Caucasian and non-Caucasian
populations [5-8,14-20]. While the differences in terms of
low percentages observed in isolated genes could be con-
nected with the primers that we used in typing, since these
may have recognized alleles that were not evaluated in
early published studies, the opposite should not apply:
where older methods developed more positivity than ours
(as with KIR2DL2 in the Australian Aborigine and North
Indian populations), our results must be taken as signifi-
cant.
The three populations that show most markedly different
patterns from ours are the Australian Aborigine, Chinese
Han and Japanese, in particular for inhibitor genes
KIR2DL2  and non inhibitor KIR2DS1,  KIR2DS2,
KIR2DS3, KIR3DS1, which have a significant difference
from our Italian study, as indeed from other Caucasian
population evaluations [6,17,18].
For the Chinese Han population study the same primers
were used as in our own and hence form a valid point of
comparison. In particular, inhibitor genes such as
KIR2DL2 and KIR2DL5B were found in an extremely low
percentage, as was the non inhibitor gene KIR2DS3.
KIR2DS4 alleles are especially interesting since the Chi-
nese pattern is exactly the inverse of the Italian [17].
KIR2DL1 and KIR2DL3 are observed in high positive link-
age disequilibrium as detected in other Caucasian and
non-Caucasian populations and this datum further sug-
gests a segregation of KIR region haplotypes into two
groups distinguished by KIR2DL1/KIR2DL3  and
KIR2DL2, although the latter is claimed to have arisen as
a recombination event between KIR2DL1 and KIR2DL3
[22].
A negative linkage disequilibrium was identified between
KIR2DS4*001/002  and  KIR2DS4*003, suggesting their
alleles may not be identical, as already confirmed in other
Caucasian and non-Caucasian populations [23].
The KIR repertoire is substantially influenced by the poly-
morphic and polygenic nature of the KIR gene. However,
using primers to identify the two variants of KIR2DL5
(2DL5A, 2DL5B) and the allele KIR2DS4*003, each geno-
type described by Uhrberg might be assigned to a haplo-
type with more than one combination [4,23,24].
In this study we observed that genotype 1is the most rep-
resentative, as in other Caucasian populations, and our
data are in agreement with other studies on Caucasian
populations concerning the predominance of the haplo-
type A group over the haplotype B group [5]. This means
that 28.5% of the Italian population have KIR2DS4 as the
only activating gene. Bearing in mind the high percentage
of individuals who have only the deleted form of
KIR2DS4, this would lead to at least 18% of this popula-
tion not having a functional activating receptor, provided
that the assumption of the deleted form of KIR2DS4 not
being expressed is correct [23].
Genotype 1 is also the most frequent in the Chinese Han
non-Caucasian population but the percentage is higherJournal of Translational Medicine 2006, 4:44 http://www.translational-medicine.com/content/4/1/44
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than observed in our study (58.7% vs 28.5%). In this gen-
otype the distribution of the KIR2DS4 alleles has a com-
pletely contrary pattern to what we observed in our
population, suggesting a different positivity of the alleles
but also a different haplotype recombination in the pop-
ulations [17]. The particular distribution of KIR genes
could be due to a selection pressure, which would favour
a particular combination of KIR genes, and this phenom-
enon could be explained by the linkage disequilibium
observed.
The actual number of genotypes in the Italian study pop-
ulation is likely to be much lower higher than we sur-
mised because the medium level of resolution was only
studied for KIR2DL5 and KIR2DS4. Typings for the two
groups, alleles KIR2DL5 and KIR2DS4, already show an
increase in the variety of KIR gene profiles. Moreover the
distribution of the patterns described should be revised
because the analysis in which there was no or low discrim-
ination of alleles will have overestimated the similarities
and underestimated the differences between populations
[25,26].
Combinations of particular HLA-KIR genotypes have also
been linked with susceptibility to autoimmune diseases
such as psoriatic arthritis and type I diabetes, just as sev-
eral genetic studies have revealed an influence of HLA-KIR
gene interactions on disease outcome.
Interactions between HLA-Bw4 and KIR3DS1 gene have
been observed in cases of delayed progression to AIDS in
HIV patients, while the homozygosity of both HLA-C1
and KIR2DL3 is associated with resolution of hepatitis C
virus infection. Understanding the basis for these
observed genetic associations is complicated by the exten-
sive polymorphism found among KIR haplotypes, which
differ not only in nucleotide sequence but also in gene
content [27].
In having established the percentage of the population
positive for a KIR gene and the distribution of KIR geno-
typing, the present study may serve as a reference for other
studies of genetic associations between KIR genes and spe-
cific diseases.
Recently several reports have described a role for KIR
genes in bone marrow transplantation. At present the
approach to identification of NK alloreactive donors in
haploidentical bone marrow transplants has been based
on KIR ligand incompatibility [11]. However this incom-
patibility has also been shown in HLA-identical sibling
transplantation [28]. Therefore the availability of a sim-
ple, reproducible molecular biology test such as we have
used in this study to type the KIR genes could become part
of donor evaluation and selection, since it directly identi-
fies the presence or absence of a given KIR gene in the
donor. One important example of this is the lack of the
KIR3DL1 gene for HLA-Bw4 inhibitory receptors, which
immediately excludes about 4% of potential donors.
In broad conclusion, our study shows that the Italian pop-
ulation possesses the general KIR gene features reported in
other Caucasian and non-Caucasian populations, but the
discrepancies in the case of certain genes confirm the pol-
ymorphic and polygenic nature of the KIR genes in the
population.
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